Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett 6, 55 Fruit Street, Boston, MA 02114, USA.
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett 6, 55 Fruit Street, Boston, MA 02114, USA.
Hematol Oncol Clin North Am. 2021 Feb;35(1):29-56. doi: 10.1016/j.hoc.2020.08.010. Epub 2020 Oct 26.
Melanoma skin cancer is derived from skin melanocytes and has a high risk of metastatic spread. The era of molecular genetics and next-generation sequencing has uncovered the role of oncogenic BRAFV600E mutations in many melanomas, validated the role of ultraviolet-induced DNA mutations in melanoma formation, and uncovered many of the molecular events that occur during melanoma development. Targeted therapies and immunotherapy have dramatically improved outcomes and provided an increased rate of cure for metastatic melanoma. This article reviews the formation of melanoma, the molecular events involved in melanoma growth and metastasis, and the biology underlying resistance to melanoma therapies.
黑色素瘤是一种源自皮肤黑素细胞的皮肤癌,具有很高的转移扩散风险。分子遗传学和下一代测序时代揭示了 BRAFV600E 突变在许多黑色素瘤中的致癌作用,验证了紫外线诱导的 DNA 突变在黑色素瘤形成中的作用,并揭示了黑色素瘤发展过程中发生的许多分子事件。靶向治疗和免疫疗法显著改善了转移性黑色素瘤的预后,并提高了治愈率。本文综述了黑色素瘤的形成、黑色素瘤生长和转移涉及的分子事件,以及黑色素瘤治疗耐药的生物学基础。